Clinical implementation of cancer genomic medicine using gene profiling test under national health insurance in Japan

被引：0
|
作者：
Fukada, Ippei [1 ,2 ]
Hayashi, Naomi [1 ,3 ]
Yamazaki, Masumi [1 ,4 ]
Oh, Gyohi [1 ,3 ]
Hosonaga, Mari [2 ]
Nakajima, Takeshi [5 ]
Mori, Seiichi [6 ]
Takeuchi, Kengo [7 ]
Takahashi, Shunji [1 ,3 ,4 ]
机构：
[1] Japanese Fdn Canc Res, Canc Inst Hosp, Genom Med, Tokyo, Japan
[2] Japanese Fdn Canc Res, Canc Inst Hosp, Breast Med Oncol, Tokyo, Japan
[3] Japanese Fdn Canc Res, Canc Inst Hosp, Med Oncol, Tokyo, Japan
[4] Japanese Fdn Canc Res, Canc Inst Hosp, Ctr Adv Med Dev, Tokyo, Japan
[5] Japanese Fdn Canc Res, Canc Inst Hosp, Clin Genet, Tokyo, Japan
[6] Japanese Fdn Canc Res, Canc Inst, Div Canc Genom, Tokyo, Japan
[7] Japanese Fdn Canc Res, Canc Inst Hosp, Clin Pathol Ctr, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.05.582
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO9-5
引用
收藏
页码：S301 / S301
页数：1
相关论文
共 50 条
  • [21] Genomic landscape of colorectal cancer in Japan: clinical implications of comprehensive genomic sequencing for precision medicine
    Nagahashi, Masayuki
    Wakai, Toshifumi
    Shimada, Yoshifumi
    Ichikawa, Hiroshi
    Kameyama, Hitoshi
    Kobayashi, Takashi
    Sakata, Jun
    Yagi, Ryoma
    Sato, Nobuaki
    Kitagawa, Yuko
    Uetake, Hiroyuki
    Yoshida, Kazuhiro
    Oki, Eiji
    Kudo, Shin-ei
    Izutsu, Hiroshi
    Kodama, Keisuke
    Nakada, Mitsutaka
    Tse, Julie
    Russell, Meaghan
    Heyer, Joerg
    Powers, Winslow
    Sun, Ruobai
    Ring, Jennifer E.
    Takabe, Kazuaki
    Protopopov, Alexei
    Ling, Yiwei
    Okuda, Shujiro
    Lyle, Stephen
    GENOME MEDICINE, 2016, 8
  • [22] Genomic landscape of colorectal cancer in Japan: clinical implications of comprehensive genomic sequencing for precision medicine
    Masayuki Nagahashi
    Toshifumi Wakai
    Yoshifumi Shimada
    Hiroshi Ichikawa
    Hitoshi Kameyama
    Takashi Kobayashi
    Jun Sakata
    Ryoma Yagi
    Nobuaki Sato
    Yuko Kitagawa
    Hiroyuki Uetake
    Kazuhiro Yoshida
    Eiji Oki
    Shin-ei Kudo
    Hiroshi Izutsu
    Keisuke Kodama
    Mitsutaka Nakada
    Julie Tse
    Meaghan Russell
    Joerg Heyer
    Winslow Powers
    Ruobai Sun
    Jennifer E. Ring
    Kazuaki Takabe
    Alexei Protopopov
    Yiwei Ling
    Shujiro Okuda
    Stephen Lyle
    Genome Medicine, 8
  • [23] Clinical application of a cancer genomic profiling assay to guide precision medicine decisions
    Eifert, Cheryl
    Pantazi, Angeliki
    Sun, Ruobai
    Xu, Jia
    Cingolani, Pablo
    Heyer, Joerg
    Russell, Meaghan
    Lvova, Maria
    Ring, Jennifer
    Tse, Julie Y.
    Lyle, Stephen
    Protopopov, Alexei
    PERSONALIZED MEDICINE, 2017, 14 (04) : 309 - 325
  • [24] Implementation and yield of upfront genomic profiling in a clinical prostate cancer diagnostic pathway
    Massie, Charlie
    Gnanapragasam, Vincent J.
    Barrett, Tristan
    Warren, Anne
    Anand, Shubha
    Keates, Alexandra
    Pacey, Simon
    BJU INTERNATIONAL, 2023, 132 (05) : 499 - 501
  • [25] Clinical impact of a cancer genomic profiling test using an in-house comprehensive targeted sequencing system
    Hayashi, Hideyuki
    Tanishima, Shigeki
    Fujii, Kyoko
    Mori, Ryo
    Okada, Chihiro
    Yanagita, Emmy
    Shibata, Yuka
    Matsuoka, Ryosuke
    Amano, Toraji
    Yamada, Takahiro
    Yabe, Ichiro
    Kinoshita, Ichiro
    Komatsu, Yoshito
    Dosaka-Akita, Hirotoshi
    Nishihara, Hiroshi
    CANCER SCIENCE, 2020, 111 (10) : 3926 - 3937
  • [26] Impact of reimbursement restriction on drug market sales under the National Health Insurance in Japan
    Mamiya, Hiroaki
    Igarashi, Ataru
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 206 - 211
  • [27] "PleSSision": A Pathologist Edited Multigene Genomic Test Promotes Cancer Precision Medicine in Japan
    Aimono, E.
    Yanagita, E.
    Matsuoka, R.
    Kato, Y.
    Hayashi, H.
    Imai, M.
    Tanishima, S.
    Nishihara, H.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 1011 - 1011
  • [28] Critical care medicine in Taiwan from 1997 to 2013 under National Health Insurance
    Lai, Chih-Cheng
    Ho, Chung-Han
    Chang, Chia-Li
    Chen, Chin-Ming
    Chiang, Shyh-Ren
    Chao, Chien-Ming
    Wang, Jhi-Joung
    Cheng, Kuo-Chen
    JOURNAL OF THORACIC DISEASE, 2018, 10 (08) : 4957 - 4965
  • [29] How are new drugs disseminated in Japan? Analysis using the National Database of Health Insurance Claims of Japan
    Watanabe, Tomone
    Sugiyama, Takehiro
    Imai, Kenjiro
    Higashi, Takahiro
    CANCER SCIENCE, 2022, 113 (05) : 1771 - 1778
  • [30] Implementation of in-house clinical sequencing system for precision cancer medicine in Japan
    Sunami, Kuniko
    Kubo, Takashi
    Kato, Mamoru
    Ichikawa, Hitoshi
    Yamamoto, Noboru
    Kohno, Takashi
    CANCER SCIENCE, 2018, 109 : 816 - 816
12345